Cargando…
Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates
Matuzumab and nimotuzumab are anti-EGFR monoclonal antibodies that bind to different epitopes of domain III of EGFR. We developed (89)Zr-matuzumab as a PET probe for diagnosis/monitoring of response to treatment of a noncompeting anti-EGFR nimotuzumab antibody drug conjugate (ADC) using mouse colore...
Autores principales: | Tikum, Anjong Florence, Nambisan, Anand Krishnan, Ketchemen, Jessica Pougoue, Babeker, Hanan, Khan, Musharraf N., Torlakovic, Emina E., Fonge, Humphrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505583/ https://www.ncbi.nlm.nih.gov/pubmed/36145664 http://dx.doi.org/10.3390/pharmaceutics14091917 |
Ejemplares similares
-
Engineering of a Fully Human Anti-MUC-16 Antibody and Evaluation as a PET Imaging Agent
por: Babeker, Hanan, et al.
Publicado: (2022) -
Reduced Graphene Oxide-Oligonucleotide Interfaces:
Understanding Based on Electrochemical Oxidation of Guanines
por: Tikum, Anjong Florence, et al.
Publicado: (2018) -
3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022) -
Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity
por: Panosa, Clara, et al.
Publicado: (2013) -
Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft
por: Hartimath, Siddesh V., et al.
Publicado: (2019)